Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
08 Dec 2016 | 12:00 AM
Research Report
Weekly

Equity Research Report: Master Pick- IPCA Laboratories Limited

IPCA Laboratories is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. The domestic business has been a key growth driver for IPCA Lab as the company changed focus from the low margin anti-malarial segment to focus on higher margin chronic/lifestyle diseases.
04 Dec 2015 | 06:00 PM

IPCA Laboratories is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.


The domestic business has been a key growth driver for IPCA Lab as the company changed focus from the low margin anti-malarial segment to focus on higher margin chronic/lifestyle diseases.

The market conditions are no different in last nine months but it’s still trading well above its long term averages on multiple time frames and looks upbeat to retest its previous record high. Considering the given factors, it’s prudent for traders to accumulate it in the given range of 755-774 with close below stop loss of 705 for the target of 940.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.